Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

PFIZER vs MYLAN (US) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More


Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More



5-Yr Chart
Click to enlarge
High Rs2,3654,175-   
Low Rs1,6252,942-   
Sales per share (Unadj.) Rs430.31,429.3-  
Earnings per share (Unadj.) Rs78.7172.2-  
Cash flow per share (Unadj.) Rs93.2277.1-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.5710.5-  
Shares outstanding (eoy) m45.75378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x4.62.5 186.2%   
Avg P/E ratio x25.320.7 122.6%  
P/CF ratio (eoy) x21.412.8 166.7%  
Price / Book Value ratio x3.45.0 67.9%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2711,346,445 6.8%   
No. of employees `0002.625.0 10.5%   
Total wages/salary Rs m3,1430-   
Avg. sales/employee Rs Th7,484.821,631.4 34.6%   
Avg. wages/employee Rs Th1,195.00-   
Avg. net profit/employee Rs Th1,369.12,605.9 52.5%   
Net Sales Rs m19,685540,786 3.6%  
Other income Rs m1,143-3,152 -36.3%   
Total revenues Rs m20,828537,634 3.9%   
Gross profit Rs m5,003134,496 3.7%  
Depreciation Rs m66339,718 1.7%   
Interest Rs m423,327 0.0%   
Profit before tax Rs m5,47968,299 8.0%   
Minority Interest Rs m0-280 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8782,872 65.4%   
Profit after tax Rs m3,60165,147 5.5%  
Gross profit margin %25.424.9 102.2%  
Effective tax rate %34.34.2 815.3%   
Net profit margin %18.312.0 151.8%  
Current assets Rs m24,167475,422 5.1%   
Current liabilities Rs m9,544371,685 2.6%   
Net working cap to sales %74.319.2 387.2%  
Current ratio x2.51.3 198.0%  
Inventory Days Days5578 70.6%  
Debtors Days Days29107 26.8%  
Net fixed assets Rs m9,514125,109 7.6%   
Share capital Rs m45819,124 2.4%   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,832268,824 10.0%   
Long term debt Rs m25401,597 0.0%   
Total assets Rs m36,9001,082,798 3.4%  
Interest coverage x1,305.53.9 33,237.6%   
Debt to equity ratio x01.5 0.1%  
Sales to assets ratio x0.50.5 106.8%   
Return on assets %9.88.2 119.6%  
Return on equity %13.424.2 55.4%  
Return on capital %20.413.6 149.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
From Operations Rs m3,31871,087 4.7%  
From Investments Rs m-2,383-56,061 4.3%  
From Financial Activity Rs m-1,104-18,731 5.9%  
Net Cashflow Rs m-169-3,706 4.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 70.05 Rs / USD

Compare PFIZER With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  


Today's Market

Sensex Ends 324 Points Lower; Metal and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Apr 25, 2019 (Close)